论文信息 - Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study - 字舞流文

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

I. Frank | P. Goepfert | S. Gurunathan | C. Diazgranados | M. Koutsoukos | G. de Bruyn | Jon Smith | L. Schuerman | L. Sher | M. Kimmel | M. Keefer | Anne-Laure Chabanon | F. Tavares-da-Silva | M. Bonaparte | H. Schwartz | S. Savarino | B. Essink | B. Fu | H. Janosczyk | R. Masotti | O. Haney | M. Davis